New eye drop combo aims to lower glaucoma pressure
NCT ID NCT07354516
First seen Jan 25, 2026 · Last updated Apr 30, 2026 · Updated 16 times
Summary
This study is testing a new preservative-free eye drop combination (QLS-111-FDC) to see how well it lowers eye pressure in people with open-angle glaucoma or ocular hypertension. About 60 participants will receive the study drops and be monitored for safety and comfort. The goal is to find a better way to manage these chronic eye conditions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OAG - OPEN-ANGLE GLAUCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shettle Eye Research
RECRUITINGLargo, Florida, 33773, United States
Conditions
Explore the condition pages connected to this study.